Comments: Molecular data for this nominal taxon is still lacking.
A current focus is on content-based radiological image retrieval and integration of imaging features with clinical and molecular data for diagnostic, prognostic, and therapy planning decision support.
In this collaborative case series, we present clinical and molecular data for 14 previously unreported individuals from 11 unrelated families who harbor compound heterozygous or homozygous TANGO2 variants, expanding the molecular profile and clinical phenotype of TANGO2-related disorder.
In recent biomedical science, clinical and molecular data for Kampo medicine-based pharmacotherapy have been accumulated, and a variety of omics data are becoming available in the genome, transcriptome, proteome, metabolome, phenome, and diseasome.
We obtained molecular data for three nuclear and mitochondrial loci (28S, 18S, and 16S), both from fresh collected specimens and culture isolates.
This sets the stage for further applications of this model to other conditions, answering an increasing demand for robust delivery of molecular data for individualized medicine.
It throws into sharp relief the relative strengths and shortcomings of the combined molecular data for assessing this challenging phylogenetic problem, and thereby provides useful pointers for future studies.
Whenever such papers are submitted they should be submitted with appropriate molecular data for them to be considered.
The use of limited molecular data for inferences about species identification and discovery points to some interesting philosophical issues.
It needs to be considered that owing to the lack of molecular data for histological analysis, tumour classification was based on the WHO classification from 2007 instead of the new one from 2016, which includes molecular parameters [18, 29].
However, there is still a lack of broad geographic coverage of molecular data for Simocephalus.
